[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_9110 

# __Lack of effective treatment for baylisascariasis__

## Articles mentionning the risk

* [Guo_aerosol_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_477.md)

## Mitigations of this risk

* [Research and development of effective treatments for baylisascariasis](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_11008.md)

## Name of the risk

Limited options for treating the disease

## People affected by this risk

* [Patients with baylisascariasis](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_7427.md)

## Stakeholders who can mitigate this risk

* [Medical researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_685.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Medical research and development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_7942.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Poor access to diagnostics and treatment](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_41.md)

